PharmaBoardroom

Biosimilars & Biologics: Bulgaria

All legal aspects surrounding localization in Bulgaria. Prepared in association with Kinstellar and PharmDedict, this is an extract from The Pharma…

Localization: Bulgaria

All legal aspects surrounding localization in Bulgaria. Prepared in association with Kinstellar and PharmDedict, this is an extract from The Pharma…

Switzerland’s Quest for Alternatives to Animal Testing of…

Animal testing for medicinal purposes is back under the spotlight in Switzerland after a petition against the practice filed in Bern managed to…

Orphan Drugs & Rare Diseases: Bulgaria

Keen to learn more about orphan drugs & rare diseases in Bulgaria? Read on! Prepared in association with Kinstellar and PharmDedict, this is an…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Bulgaria

The key facts about the cannabinoids drugs in Bulgaria. Prepared in association with Kinstellar and PharmDedict, this is an extract from The Pharma…

Biosimilars & Biologics: Japan

The key facts about biosimilars and biologics in Japan. Prepared in association with Nishimura & Asahi, a leading law firm in Japan, this is an…

Cyril Titeux – Senior VP Mid-sized Markets EMEA &…

Janssen’s Cyril Titeux highlights the commonalities and challenges within his 31-country portfolio, his hopes and expectations for the evolution of…

Localization: Japan

The key facts about localization in Japan. Prepared in association with Nishimura & Asahi, a leading law firm in Japan, this is an extract…

Localization: Indonesia

The key facts about localization in the Indonesian pharma market. Prepared in association with ABNR, a leading global law firm, this is an extract…

Regulatory Reforms: UAE

The key facts about regulatory reforms in the UAE. Prepared in association with STA, a leading law firm in the UAE, this is an extract from The Pharma…

Patents & Trademarks: UAE

The key facts about patents & trademarks in the UAE. Prepared in association with STA, a leading law firm in the UAE, this is an extract from The…

Vincent Gruntz – General Manager Oncology, Novartis Pharma…

Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement…

Tagged with